Product divestment can be a time-consuming and costly process for manufacturers whose assets are no longer the right fit for their portfolio. The Matrix Healthcare Solutions (MHS) team are experienced with complex divestments, and actively seek products that are being considered for withdrawal on a regional or global basis. In many of these cases, products have complicated manufacturing, regulatory, and licensing conditions – which is why many product divestment challenges arise.

At MHS, the express aim is to maintain the unbroken supply of essential medicines to physicians and their patients. Many reasons can underlie product withdrawals. Outdated manufacturing plants and processes, low margins, changes to product use, increased supply costs, ever-increasing regulatory costs, continued downward pressure on a realized sale price, and mergers and acquisitions are just a handful. These are challenges that the MHS team excel at solving. Contact us today if you would like to learn more.